by Xcellerant Ventures | Jan 25, 2024 | Portfolio Company News
Origionally posted on TTI’s website: https://tti.care/patient-risk-management-platform-wave-health-delivers-rare-93-patient-compliance-and-98-hcp-perceived-usefulness/ Presented at the 2024 ASCO Genitourinary Cancers Symposium, PRO-WAVE1 Research Results...
by Xcellerant Ventures | Jan 24, 2024 | Portfolio Company News
Origionally posted on Biz Journals- AZ INNO:...
by Xcellerant Ventures | Jan 16, 2024 | Portfolio Company News
Origionally posted on PR Newswire: https://www.prnewswire.com/news-releases/dr-ghassan-kassab-joins-anuncia-medicals-board-elevating-future-product-innovation-302035828.html SCOTTSDALE, Ariz., Jan. 16, 2024 /PRNewswire/ — Anuncia Medical Inc....
by Xcellerant Ventures | Jan 12, 2024 | Portfolio Company News, Xcellerant Ventures News
Why Xcellerant Ventures Invested in CRISPR QC The Xcellerant Venture’s team is proud to lead a Series A funding round for CRISPR QC, the San Diego-based biotechnology company that has developed the world’s first and only CRISPR Analytics Platform. This platform...
by Xcellerant Ventures | Jan 9, 2024 | Portfolio Company News
Origionally posted on Business Wire: https://www.businesswire.com/news/home/20240109962697/en/TruLite-Health-Announces-Collaboration-with-Mayo-Clinic-to-Address-Clinical-Bias-Improve-Health-Equity TEMPE, Ariz.–(BUSINESS WIRE)–TruLite Health, developer of...
